Searchable abstracts of presentations at key conferences in endocrinology

ea0092op-03-02 | Oral Session 3: Signalling in Thyroid cancer | ETA2023

Determination of the role of map kinase and PI3K/AKT signaling pathways in the regulation of multidrug resistance proteins in thyroid cancer

Godlewska Marlena , Ratajczak Maciej , Gajda Ewa , Gawel agata , Zebracka-Gala Jadwiga , Cieślicka Marta , Oczko-Wojciechowska Malgorzata , Kowalska Malgorzata , Gawel Damian

Thyroid cancer (TC) has one of the fastest increasing incidences worldwide and primarily involves papillary thyroid cancer (PTC). Cancer cells have numerous mechanisms that govern drug resistance, among which activation of multidrug resistance (MDR) genes encoding ABC efflux pumps plays an important role. Acquisition of drug resistance by TC cells is becoming a significant obstacle to effective therapy, leading to insensitivity to classical chemotherapeutics, but also to speci...

ea0099p160 | Thyroid | ECE2024

New plasma biomarkers: XIAP and survivin in patients with medullary thyroid cancer (MTC)

Glinicki Piotr , Szatko Alicja , Żyłka Agnieszka , Długosińska Joanna , Ostrowska Magdalena , Gietka-Czernel Małgorzata , Ratajczak Maciej , Zgliczyński Wojciech , Dedecjus Marek

Introduction: Medullary thyroid carcinoma (MTC) constitutes 3.5-5% of all thyroid cancers. Routine biochemical diagnostics include determination of calcitonin (CT), procalcitonin (PCT) and carcinoembryonic antigen (CEA). XIAP (X-linked inhibitor of apoptosis protein) and survivin belong to the family of proteins – inhibitors of apoptosis (IAP). Using tissue microarrays, the expression levels of XIAP and survivin were tested in patients with medullary thyroid cancer. The s...